Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$3.3B
Avg Funding
$133.3M
Cities
19

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Toronto, Canada
$4.4M
raised

Medicenna is a clinical stage, privately held, immuno-oncology company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Albuquerque, United States
$2.6M
raised

Imagion Biosystems is a Biotechnology Company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands
$59.2M
raised

ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, United States
$100.0M
raised

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dallas, United States
$200.0M
raised

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$805.0M
raised

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$200.0M
raised

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$3.1M
raised

Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several cancer indications.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$6.1M
raised

Zelluna Immunotherapy is a privately owned Norwegian biopharmaceutical company.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Piscataway, United States
$226.0M
raised

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Brisbane, Australia
$3.5M
raised

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$429K
raised

Avicanna is a biopharmaceutical company that focuses on the development of the medical cannabis space.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$2.5M
raised

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$460.0M
raised

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Charlottesville, United States
$32.0M
raised

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Austin, United States
$75.0M
raised

Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Heidelberg, Germany
$50.0M
raised

VERAXA Biotech specializes in ADC development combining cutting-edge solutions for targeted antibody discovery and bioconjugation.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$31.5M
raised

Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$600.0M
raised

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked